Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

2014 ACBS Landline-Cellphone Combined Prevalence Tables


TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2014

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Connecticut 210 41.4 5.4 (30.8 – 52.0) 225 41.6 5.3 (31.2 – 52.0)
District of Columbia 108 30.3 7.7 (15.2 – 45.4) 111 33.8 7.9 (18.3 – 49.3)
Georgia 132 19.9 4.3 (11.5 – 28.3) 138 20.7 4.4 (12.1 – 29.3)
Hawaii 185 26.5 4.8 (17.1 – 35.9) 195 23.8 4.4 (15.2 – 32.4)
Illinois 187 32.4 4.9 (22.8 – 42.0) 202 30.6 4.5 (21.8 – 39.4)
Indiana 488 35.4 3.2 (29.1 – 41.7) 509 33.5 3.0 (27.6 – 39.4)
Iowa 228 29.0 3.8 (21.6 – 36.4) 251 27.9 3.6 (20.8 – 35.0)
Maine 290 46.5 4.2 (38.3 – 54.7) 312 42.8 4.0 (35.0 – 50.6)
Maryland 209 30.9 5.1 (20.9 – 40.9) 218 31.1 4.9 (21.5 – 40.7)
Michigan 414 33.7 3.0 (27.8 – 39.6) 444 32.4 2.8 (26.9 – 37.9)
Mississippi 128 26.7 5.9 (15.1 – 38.3) 135 24.5 5.4 (13.9 – 35.1)
Missouri 255 38.0 4.6 (29.0 – 47.0) 260 38.6 4.7 (29.4 – 47.8)
Montana 253 30.2 4.5 (21.4 – 39.0) 264 28.3 4.2 (20.1 – 36.5)
Nebraska 681 33.8 3.1 (27.7 – 39.9) 718 30.5 2.9 (24.8 – 36.2)
Nevada 130 26.0 5.8 (14.6 – 37.4) 148 23.6 5.4 (13.0 – 34.2)
New Hampshire 219 38.6 4.4 (30.0 – 47.2) 228 36.6 4.6 (27.6 – 45.6)
New Jersey 420 35.5 3.5 (28.6 – 42.4) 448 34.7 3.3 (28.2 – 41.2)
New Mexico 230 33.7 4.6 (24.7 – 42.7) 258 30.6 4.2 (22.4 – 38.8)
New York 115 36.7 6.5 (24.0 – 49.4) 118 36.7 6.7 (23.6 – 49.8)
North Carolina 130 29.3 6.3 (17.0 – 41.6) 137 30.8 6.1 (18.8 – 42.8)
Ohio 337 26.7 3.4 (20.0 – 33.4) 359 25.8 3.3 (19.3 – 32.3)
Oklahoma 229 37.5 4.4 (28.9 – 46.1) 219 42.7 4.6 (33.7 – 51.7)
Oregon 165 27.7 5.4 (17.1 – 38.3) 191 25.0 4.7 (15.8 – 34.2)
Pennsylvania 413 37.6 3.6 (30.5 – 44.7) 431 36.1 3.5 (29.2 – 43.0)
Rhode Island 189 36.0 5.3 (25.6 – 46.4) 211 34.0 4.9 (24.4 – 43.6)
Texas 465 38.3 4.2 (30.1 – 46.5) 525 33.0 3.8 (25.6 – 40.4)
Utah 507 27.1 2.5 (22.2 – 32.0) 544 26.1 2.4 (21.4 – 30.8)
Vermont 240 42.7 3.9 (35.1 – 50.3) 254 40.7 3.8 (33.3 – 48.1)
Washington 374 36.9 4.3 (28.5 – 45.3) 389 31.3 4.1 (23.3 – 39.3)
West Virginia 237 26.3 3.4 (19.6 – 33.0) 236 27.4 3.5 (20.5 – 34.3)
Wisconsin 246 44.0 5.2 (33.8 – 54.2) 254 45.1 5.0 (35.3 – 54.9)
Puerto Rico 352 24.9 3.0 (19.0 – 30.8) 390 25.3 2.9 (19.6 – 31.0)
32 state total 8,766 33.7 1.2 (31.3 – 36.1) 9,322 32.5 1.1 (30.3 – 34.7)
Median   33.7       31.2    
Range   19.9-46.5       20.7-45.1    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline and cell phone combined sample size excludes “DK/Refused”

§ Standard error

Confidence interval

TOP